Home › Lung Cancer › Oregon › Eugene
Lung Cancer clinical trials in Eugene, OR
5 studies for Lung Cancer are looking for participants at sites in and around Eugene (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
RecruitingPhase 3
- Oncology Associates of Oregon PC, Eugene
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- USO - Oncology Associates of Oregon, Eugene
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
RecruitingPhase 1
- USOR - Oncology Associates of Oregon, P.C, Eugene
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
RecruitingPhase 1
- Willamette Valley Cancer Institute and Research Center, Eugene
MYLUNG Consortium Part 3: Observational Study
RecruitingObservational study
- Willamette Valley Cancer Institute and Research Center, Eugene
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Washington, DC41 studies
- Arlington, VA41 studies
- Chicago, IL41 studies
- Nashville, TN40 studies
- Baltimore, MD40 studies
- St. Louis, MO39 studies
- Columbus, OH37 studies
- Philadelphia, PA36 studies
Other studies in Eugene
- Non-Small Cell Lung Cancer13 studies
- Ovarian Cancer9 studies
- Endometrial Cancer8 studies
- Breast Cancer7 studies
- Chronic Lymphocytic Leukemia6 studies
- Multiple Myeloma6 studies
- Metastatic Cancer6 studies
- Cancer (all types)6 studies
- Drug Use and Addiction5 studies
- Macular Degeneration5 studies
- Obesity4 studies
- Prostate Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.